Connect with others who understand.

sign up log in
About mySMAteam

Connect with others who understand.

sign up log in
About mySMAteam
SMA
NEWS

New Trial Will Test Higher Dose of Nusinersen for People With Later-Onset SMA

Posted on October 05, 2021
Medically reviewed by
Evelyn O. Berman, M.D.
Article written by
Emily Wagner, M.S.

  • A new clinical trial will study whether a higher dose of nusinersen will help people with spinal muscular atrophy (SMA).
  • The trial will begin enrolling participants this year.
  • Trial participants must be between the ages of 5 and 39, have later-onset SMA, and have already been treated with risdiplam.

A new worldwide clinical trial will test the safety and efficacy of higher doses of nusinersen, sold under the brand name Spinraza, for people with spinal muscular atrophy. The ASCEND study will include children, teens, and adults with SMA.

ASCEND will study the effects of higher doses of nusinersen in people who have previously been treated with risdiplam, which is sold under the brand name Evrysdi. Researchers are hoping to enroll participants in 2021. The study is planned to last 2.5 years.

The goal is to include as many as 135 participants between the ages of 5 and 39 years who have later-onset nonambulatory SMA. Each must have taken risdiplam before. During the study, the participants will be given two initial 50-milligram doses of nusinersen two weeks apart, and then they will take 28-milligram doses every four months for the rest of the study.

Nusinersen was approved in 2016 by the U.S. Food and Drug Administration (FDA) to treat SMA types 1, 2, and 3. Currently, the FDA-approved dose of nusinersen is 12 milligrams, which is injected into the fluid surrounding the spinal cord (known as an intrathecal injection).

Doctors and researchers hope that increasing the dose of nusinersen can help fill the gaps in treatment in people treated with risdiplam. Current research suggests the concentration of risdiplam in the body decreases as people grow and age, making the medication less effective over time. A risdiplam dose is capped at 5 milligrams once a child weighs around 44 pounds.

Dr. Maha Radhakrishnan, chief medical officer at Biogen, said in a press release, “We believe that lower drug exposure may be contributing to less-than-optimal treatment outcomes for some patients treated with Evrysdi. The ASCEND study seeks to understand if nusinersen may address that unmet medical need and will help inform the future of SMA treatment, with the hope of improving patients’ outcomes for the long term.”

Due to nusinersen’s relatively recent FDA approval, researchers are continuing to examine the long-term effects of the medication. One study of 20 infants with SMA has measured the effects of nusinersen treatment over three years. Researchers found that nusinersen improved survival and helped the infants reach developmental milestones over the duration of the study.

All updates must be accompanied by text or a picture.
Evelyn O. Berman, M.D. is a neurology and pediatric specialist and treats disorders of the brain in children. Review provided by VeriMed Healthcare Network. Learn more about her here.
Emily Wagner, M.S. holds a Master of Science in biomedical sciences with a focus in pharmacology. She is passionate about immunology, cancer biology, and molecular biology. Learn more about her here.

Related articles

About one-third of people with spinal muscular atrophy (SMA) are adults.Adults with SMA may have...

Treatment Options for Adults with SMA

About one-third of people with spinal muscular atrophy (SMA) are adults.Adults with SMA may have...
Clinical trials may test new drugs or new dosages or combinations of drugs for spinal muscular...

5 Reasons To Consider Participating in SMA Clinical Trials

Clinical trials may test new drugs or new dosages or combinations of drugs for spinal muscular...
Clinical trials for spinal muscular atrophy (SMA) test new treatments, new dosages of existing...

How Do Clinical Trials Work for SMA?

Clinical trials for spinal muscular atrophy (SMA) test new treatments, new dosages of existing...
Clinical trials are designed with safety as a primary concern.Before a new drug, new dosage, or...

Are Clinical Trials Safe for People With SMA?

Clinical trials are designed with safety as a primary concern.Before a new drug, new dosage, or...
Costs for spinal muscular atrophy (SMA) medications are high, but financial assistance programs...

Tips for Staying on Spinal Muscular Atrophy (SMA) Therapies

Costs for spinal muscular atrophy (SMA) medications are high, but financial assistance programs...
Spinal muscular atrophy (SMA) is a genetic, neuromuscular disorder. Because SMA is mostly driven...

Understanding How SMA Gene Therapy Works

Spinal muscular atrophy (SMA) is a genetic, neuromuscular disorder. Because SMA is mostly driven...

Recent articles

The SMA community officially recognizes August as Spinal Muscular Atrophy Awareness Month. In...

UCSF Health and mySMAteam Partnership: SMA Awareness Month 2022

The SMA community officially recognizes August as Spinal Muscular Atrophy Awareness Month. In...
The Centers for Disease Control and Prevention (CDC) has approved a second COVID-19 booster shot...

What People With SMA Should Know About Getting a Second COVID-19 Booster Shot

The Centers for Disease Control and Prevention (CDC) has approved a second COVID-19 booster shot...
Historically, spinal muscular atrophy (SMA) has been difficult to diagnose. The doctors I saw as...

Learning Self-Advocacy at a Young Age: My Experiences

Historically, spinal muscular atrophy (SMA) has been difficult to diagnose. The doctors I saw as...
People in online gaming communities have a wide range of personalities, outlooks, and behaviors —...

Gaming With SMA: Beware of Trolls and Hackers

People in online gaming communities have a wide range of personalities, outlooks, and behaviors —...
Becoming a better gamer can enhance your enjoyment and expand your gaming opportunities. Getting...

Gaming With SMA: Leveling Up Your Gaming Skills

Becoming a better gamer can enhance your enjoyment and expand your gaming opportunities. Getting...
When you first get started with online gaming, finding friends can feel virtually impossible...

Gaming With SMA: Finding Friends in Online Gaming

When you first get started with online gaming, finding friends can feel virtually impossible...
SMA News
SMA News

Thank you for subscribing!

Become a member to get even more:

sign up for free

close